(XUFN) db x-trackers MSCI USA - Ratings and Ratios
Banking, Insurance, Investments, Fintech
Description: XUFN db x-trackers MSCI USA
The db x-trackers MSCI USA Financials UCITS DR (XETRA:XUFN) is an exchange-traded fund (ETF) that tracks the Morningstar Global Financial Services Index, providing investors with exposure to the financial services sector in the US market. As a Sector Equity Financial Services ETF, it allows investors to target this specific segment of the market.
With its origins in Germany, XUFN is listed on the XETRA exchange, offering a ticker symbol for easy identification. The fund is part of the UCITS (Undertakings for Collective Investment in Transferable Securities) framework, ensuring compliance with European regulatory standards.
From a technical analysis perspective, the ETFs price action indicates a potential consolidation phase. The current price of 31.99 is below the 20-day Simple Moving Average (SMA) of 32.73, suggesting a short-term bearish trend. However, the 50-day SMA at 31.81 provides support, indicating a possible bounce. The Average True Range (ATR) of 0.45, equivalent to 1.39%, implies moderate volatility.
Fundamentally, the ETF has a substantial Assets Under Management (AUM) of 1155.16M EUR, demonstrating its popularity among investors. The underlying index, Morningstar Global Financial Services, is likely to be influenced by the performance of major US financial institutions.
Forecasting the ETFs future performance, we can expect the price to be influenced by the interplay between technical and fundamental factors. Given the current technical setup, a potential breakout above the 20-day SMA could lead to a rally towards the 52-week high of 36.97. Conversely, a failure to break above this level may result in a decline towards the 52-week low of 26.94. Fundamentally, the AUM and the underlying indexs composition will continue to drive investor interest. If the US financial sector experiences a significant shift, either positively or negatively, it is likely to impact XUFNs price action.
Based on the available data, a reasonable forecast for XUFN would be a gradual increase in price, potentially reaching 34.50, driven by a combination of technical breakout and fundamental sector growth. However, this forecast is contingent upon the ETFs ability to break above the 20-day SMA and sustain a bullish trend.
Additional Sources for XUFN ETF
XUFN ETF Overview
Market Cap in USD | 1,361m |
Category | Sector Equity Financial Services |
TER | 0.12% |
IPO / Inception | 2017-09-12 |
XUFN ETF Ratings
Growth Rating | 78.1 |
Fundamental | - |
Dividend Rating | 31.5 |
Rel. Strength | -7.41 |
Analysts | - |
Fair Price Momentum | 33.38 EUR |
Fair Price DCF | - |
XUFN Dividends
Dividend Yield 12m | 1.13% |
Yield on Cost 5y | 2.67% |
Annual Growth 5y | 9.72% |
Payout Consistency | 72.5% |
Payout Ratio | % |
XUFN Growth Ratios
Growth Correlation 3m | 62.9% |
Growth Correlation 12m | 48.4% |
Growth Correlation 5y | 83.4% |
CAGR 5y | 18.66% |
CAGR/Max DD 5y | 0.81 |
Sharpe Ratio 12m | 1.28 |
Alpha | 6.77 |
Beta | 0.766 |
Volatility | 13.36% |
Current Volume | 2.8k |
Average Volume 20d | 4.1k |
As of July 07, 2025, the stock is trading at EUR 33.18 with a total of 2,814 shares traded.
Over the past week, the price has changed by +1.58%, over one month by +1.40%, over three months by +15.18% and over the past year by +20.66%.
Yes. Based on ValueRay's Analyses, db x-trackers MSCI USA (XETRA:XUFN) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 78.09 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XUFN is around 33.38 EUR . This means that XUFN is currently overvalued and has a potential downside of 0.6%.
db x-trackers MSCI USA has no consensus analysts rating.
According to our own proprietary Forecast Model, XUFN db x-trackers MSCI USA will be worth about 38.4 in July 2026. The stock is currently trading at 33.18. This means that the stock has a potential upside of +15.82%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 38.4 | 15.8% |